首页> 外国专利> Polypeptides or nucleic acids encoding these of a family of G-protein coupled receptors and their use for the diagnosis of treatment of disorders, for example skin disorders and their use for the identification of pharmacologically active substances

Polypeptides or nucleic acids encoding these of a family of G-protein coupled receptors and their use for the diagnosis of treatment of disorders, for example skin disorders and their use for the identification of pharmacologically active substances

机译:编码G蛋白偶联受体家族的多肽或核酸,及其在诊断疾病(如皮肤疾病)中的用途,以及在鉴定药理活性物质中的用途

摘要

G protein coupled receptor polypeptide (I) is a sequence of 331 (S1), 321 (S2) or 325 (S3) amino acids, all fully defined in the specification, or their functional variants. Independent claims are also included for the following: (a) nucleic acid (II) that encodes (I); (b) cell containing (II) or transformed with a vector, knockout gene construct or expression cassette containing (II); (c) transgenic non-human mammal containing (II) (or vector, knockout gene construct or expression cassette) in its genome; (d) antibody (Ab), or its fragment, directed against (I) or (II); (e) test kit for identifying pharmacologically active substances comprising (I), (II), Ab, the cells or transgenic animals; (f) carrier-bound array of (I), (II), Ab or the cells; (g) diagnostic or therapeutic composition containing (I), (II), Ab and/or cells; (h) method for preparing (I) by expressing (II) in a cell; (i) method for preparing the transgenic animals by regenerating a transgenic embryonal stem cell containing (II); (j) method for preparing Ab by immunization; and (k) use of a similar receptor polypeptide (Ia), 330 amino acid sequence (S4) fully defined in the specification.
机译:G蛋白偶联受体多肽(I)是331(S1),321(S2)或325(S3)个氨基酸的序列,在本说明书中已完全定义,或它们的功能变异体。还包括以下方面的独立权利要求:(a)编码(I)的核酸(II); (b)含有(II)的细胞或用含有(II)的载体,基因敲除基因构建体或表达盒转化的细胞; (c)在其基因组中包含(II)(或载体,基因敲除基因构建体或表达盒)的转基因非人类哺乳动物; (d)针对(I)或(II)的抗体(Ab)或其片段; (e)鉴定包含(I),(II),Ab,细胞或转基因动物的药理活性物质的试剂盒; (f)(I),(II),Ab或细胞的载体结合阵列; (g)含有(I),(II),Ab和/或细胞的诊断或治疗组合物; (h)通过在细胞中表达(II)来制备(I)的方法; (i)通过再生含有(II)的转基因胚胎干细胞来制备转基因动物的方法; (j)通过免疫制备抗体的方法; (k)使用说明书中完全定义的相似受体多肽(Ia),330个氨基酸序列(S4)。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号